AU2796695A - Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders - Google Patents
Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disordersInfo
- Publication number
- AU2796695A AU2796695A AU27966/95A AU2796695A AU2796695A AU 2796695 A AU2796695 A AU 2796695A AU 27966/95 A AU27966/95 A AU 27966/95A AU 2796695 A AU2796695 A AU 2796695A AU 2796695 A AU2796695 A AU 2796695A
- Authority
- AU
- Australia
- Prior art keywords
- cholecystokinine
- gastrine
- treatment
- related disorders
- pyrrolidine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9407540A FR2721314B1 (fr) | 1994-06-20 | 1994-06-20 | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
FR9407540 | 1994-06-20 | ||
PCT/FR1995/000796 WO1995035310A1 (fr) | 1994-06-20 | 1995-06-16 | Derives de pyrrolidine pour le traitement des desordres lies a la cck et la gastrine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2796695A true AU2796695A (en) | 1996-01-15 |
Family
ID=9464413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27966/95A Abandoned AU2796695A (en) | 1994-06-20 | 1995-06-16 | Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
Country Status (12)
Country | Link |
---|---|
US (1) | US5716936A (da) |
EP (1) | EP0766695B1 (da) |
JP (1) | JPH10501802A (da) |
AT (1) | ATE168697T1 (da) |
AU (1) | AU2796695A (da) |
DE (1) | DE69503635T2 (da) |
DK (1) | DK0766695T3 (da) |
ES (1) | ES2119454T3 (da) |
FR (1) | FR2721314B1 (da) |
IL (1) | IL114239A0 (da) |
WO (1) | WO1995035310A1 (da) |
ZA (1) | ZA955052B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2744362B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
EP1560488B1 (en) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Antibacterial agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL74140A (en) * | 1984-04-10 | 1988-05-31 | Robins Co Inc A H | Substituted n-((amino)alkyl)-1-pyrrolidine,-1-piperidine and-1-homopiperidine-carboxamides and pharmaceutical compositions containing them |
US4642348A (en) * | 1984-04-10 | 1987-02-10 | A. H. Robins Company, Incorporated | N-(amino)alkyl)-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-positions |
US4593102A (en) * | 1984-04-10 | 1986-06-03 | A. H. Robins Company, Inc. | N-[(amino)alkyl]-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-position |
FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
-
1994
- 1994-06-20 FR FR9407540A patent/FR2721314B1/fr not_active Expired - Fee Related
-
1995
- 1995-06-16 AT AT95923397T patent/ATE168697T1/de active
- 1995-06-16 AU AU27966/95A patent/AU2796695A/en not_active Abandoned
- 1995-06-16 DK DK95923397T patent/DK0766695T3/da active
- 1995-06-16 DE DE69503635T patent/DE69503635T2/de not_active Expired - Fee Related
- 1995-06-16 EP EP95923397A patent/EP0766695B1/fr not_active Expired - Lifetime
- 1995-06-16 US US08/750,653 patent/US5716936A/en not_active Expired - Fee Related
- 1995-06-16 ES ES95923397T patent/ES2119454T3/es not_active Expired - Lifetime
- 1995-06-16 WO PCT/FR1995/000796 patent/WO1995035310A1/fr active IP Right Grant
- 1995-06-16 JP JP8501747A patent/JPH10501802A/ja active Pending
- 1995-06-19 ZA ZA955052A patent/ZA955052B/xx unknown
- 1995-06-20 IL IL11423995A patent/IL114239A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE69503635D1 (de) | 1998-08-27 |
FR2721314A1 (fr) | 1995-12-22 |
DK0766695T3 (da) | 1999-02-15 |
FR2721314B1 (fr) | 1996-07-19 |
EP0766695B1 (fr) | 1998-07-22 |
US5716936A (en) | 1998-02-10 |
ATE168697T1 (de) | 1998-08-15 |
DE69503635T2 (de) | 1999-01-28 |
ES2119454T3 (es) | 1998-10-01 |
IL114239A0 (en) | 1995-10-31 |
EP0766695A1 (fr) | 1997-04-09 |
WO1995035310A1 (fr) | 1995-12-28 |
JPH10501802A (ja) | 1998-02-17 |
ZA955052B (en) | 1996-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9503986D0 (en) | Perhydroisoindole derivatives as p substance antagonists | |
AU2797695A (en) | Thiazolidine derivatives, their preparation and drugs containing same | |
AU2672995A (en) | {a}-annelated pyrrole derivatives and pharmaceutical uses thereof | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
DK0748314T3 (da) | Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
ZA949593B (en) | N-substituted azabicycloheptane derivatives their preparation and use | |
ZA957525B (en) | Anthracycline derivatives | |
WO1996031208A3 (de) | Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten | |
AU2796695A (en) | Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders | |
ZA9480B (en) | Pyrrolidine derivatives their preparation and medicaments containing them | |
ATA57894A (de) | Mittel zur behandlung von osteoporose |